A detailed history of Wealth Spring Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Wealth Spring Partners, LLC holds 1,494 shares of AMGN stock, worth $478,916. This represents 0.3% of its overall portfolio holdings.

Number of Shares
1,494
Previous 1,514 1.32%
Holding current value
$478,916
Previous $336 Million 19.49%
% of portfolio
0.3%
Previous 0.24%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 02, 2023

SELL
$218.65 - $271.46 $4,373 - $5,429
-20 Reduced 1.32%
1,494 $401 Million
Q2 2023

Aug 03, 2023

BUY
$214.27 - $253.37 $8,142 - $9,628
38 Added 2.57%
1,514 $336 Million
Q1 2023

May 03, 2023

BUY
$225.79 - $275.2 $451 - $550
2 Added 0.14%
1,476 $357 Million
Q4 2022

Feb 09, 2023

SELL
$229.03 - $291.01 $4,122 - $5,238
-18 Reduced 1.21%
1,474 $387 Million
Q3 2022

Feb 08, 2023

BUY
$224.46 - $253.15 $334,894 - $377,699
1,492 New
1,492 $336 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Wealth Spring Partners, LLC Portfolio

Follow Wealth Spring Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Spring Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Spring Partners, LLC with notifications on news.